PROBX
Live / Applied — Second extension granted (statement of use) (as of 20 Oct 2025)
What this means for you
Not registered yet, but its 18 Jun 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98048270
- Mark type
- Stylized text
- Filed
- 18 Jun 2023
- Published for opposition
- 27 Aug 2024
- Attorney of record
- Nancy Zoubek
Goods and services
- Class 042 — Scientific and technological services: Providing online non-downloadable computer software for healthcare, medical and surgical use for targeting, sampling, and recording biological tissues, and identifying, confirming, monitoring, and treating lesions; Providing online non-downloadable software to diagnosis and treat cancer; Providing online non-downloadable software to direct and guide needles during medical and surgical procedures; Providing online non-downloadable software for needle guide system for use in a medical or surgical procedure; Providing online non-downloadable software for treatment planning and guidance for clinical, interventional, and/or diagnostic procedures regarding biological tissues; Providing online non-downloadable medical and surgical software for creating and displaying records and reports of the locations of lesions and for monitoring, managing and treating lesions; Providing online a website to enable users to track lesions and to create reports and display records of the locations of lesions and records for monitoring, managing, and treating lesions; Providing online non-downloadable software for exchanging information regarding cancer and the monitoring, screening, assessment, diagnosis, and treatment of lesions and cancer; Providing a website displaying a record of tissue sampling locations to assist with the diagnose, surveillance and treatment of cancer; Providing online a website to transmit, store, retrieve, print, process, and display medical imaging information to enable users to screen and make assessment of cancer, and monitor, diagnose, and treat lesions; Software as a service (SAAS) services, namely, hosting software for use by patients, providers and researchers, related to identifying, targeting, and the sampling of biological tissues, lesions and cancer and recording, confirming, monitoring, and treating biological tissues, lesions and cancer.
Owner
- Probx Health, LLC, New York, NY, US
- Probx Health, LLC, New York, NY, US
Prosecution history
- 21 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Oct 2025 — SOU EXTENSION 2 GRANTED
- 20 Oct 2025 — SOU EXTENSION 2 FILED
- 20 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Apr 2025 — SOU EXTENSION 1 GRANTED
- 21 Apr 2025 — SOU EXTENSION 1 FILED
- 21 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Aug 2024 — PUBLISHED FOR OPPOSITION
- 07 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE